InVirtuoLabs unveils AI-powered platform to accelerate drug discovery

The Lugano-based biotech startup launches InVirtuo Platform, a modular AI-driven solution already applied to a proprietary metabolic disease project. With the first application targeting metabolic disorders, the startup has ongoing projects with several pharmaceutical and biotech firms.

To read the full article, click here.